Skip to main content
OpenTrials
Completed

NCT Number: NCT04662268

Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis

Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic colitis and therefore possibly modify the therapeutic management (propose surgical treatment for a severe form based on prognostic score).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > or = at 18 years old;
  • Performing an abdomino-pelvic scan injected within 6 hours of the onset of symptoms;
  • Ischemic colitis proven by endoscopy or surgical data.

Exclusion criteria

  • CT scan performed without injection and / or after 6 hours following the onset of symptoms;
  • Unproven ischemic colitis.

Treatment and study plan

Primary outcomes

  1. Complication rate of ischemic colitis

    Time frame: 1 day

    Severe (surgery and/or death) or non severe form of ischemic colitis (medical treatment) : analysis of radiological, biological and clinical data is performed at the time of acute episode of ischemic colitis when the patient is admitted to the hospital or during the stay of the patient previously present in the hospital for another condition

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier

Important dates

Study start
2014
Primary completion
2020
Study completion
2020
First posted
Dec 10, 2020
Registry last updated
Dec 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.